Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry|November 7, 2012
3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agentsCody Kelley, Yongzheng Zhang, Ajit Parhi, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2012
Antibacterial activity of substituted dibenzo[a,g]quinolizin-7-ium derivativesAjit Parhi, Songfeng Lu, Cody Kelley, et al.
Biochemical Pharmacology|October 24, 2013
Pharmacokinetics and in vivo antistaphylococcal efficacy of TXY541, a 1-methylpiperidine-4-carboxamide prodrug of PC190723Malvika Kaul, Lilly Mark, Yongzheng Zhang, et al.
International Journal of Pharmaceutics|September 30, 2014
TXA497 as a topical antibacterial agent: comparative antistaphylococcal, skin deposition, and skin permeation studies with mupirocinMania Dorrani, Malvika Kaul, Ajit Parhi, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2006
Synthesis and G-quadruplex stabilizing properties of a series of oxazole-containing macrocyclesGurpreet Singh Minhas, Daniel S Pilch, John E Kerrigan, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2013
An FtsZ-targeting prodrug with oral antistaphylococcal efficacy in vivoMalvika Kaul, Lilly Mark, Yongzheng Zhang, et al.
Biochimie|April 29, 2008
Targeting human telomeric G-quadruplex DNA with oxazole-containing macrocyclic compoundsDaniel S Pilch, Christopher M Barbieri, Suzanne G Rzuczek, et al.
Journal of Medicinal Chemistry|April 3, 2010
Macrocyclic pyridyl polyoxazoles: selective RNA and DNA G-quadruplex ligands as antitumor agentsSuzanne G Rzuczek, Daniel S Pilch, Angela Liu, et al.
Antibiotics (Basel, Switzerland)|March 27, 2024
A FtsZ Inhibitor That Can Utilize Siderophore-Ferric Iron Uptake Transporter Systems for Activity against Gram-Negative Bacterial PathogensEric J Bryan, Qi Qiao, Yuxuan Wang, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|April 17, 2023
Combination with a FtsZ inhibitor potentiates the in vivo efficacy of oxacillin against methicillin-resistant <i>Staphylococcus aureus</i>Malvika Kaul, Edgar Ferrer-González, Lilly Mark, et al.
Pageof 6